Cellectis to Hold Shareholder Meeting June 28
Ticker: CLLS · Form: 6-K · Filed: May 24, 2024 · CIK: 1627281
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, filing-announcement
TL;DR
Cellectis shareholder meeting set for June 28th in Paris.
AI Summary
Cellectis S.A. announced its Combined General Meeting of Shareholders will be held on June 28, 2024, at 2:30 p.m. Paris time. The meeting will take place at the Biopark auditorium in Paris, France. The Notice of Combined General Meeting of Shareholders is attached as an exhibit to this filing.
Why It Matters
Shareholder meetings are crucial for corporate governance, allowing investors to vote on important company matters and hear updates directly from management.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a shareholder meeting and does not contain material financial or operational changes.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- June 28, 2024 (date) — Date of Combined General Meeting of Shareholders
- 2:30 p.m. (Paris time) (time) — Start time of Combined General Meeting of Shareholders
- Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France (location) — Location of Combined General Meeting of Shareholders
FAQ
When will Cellectis S.A. hold its Combined General Meeting of Shareholders?
Cellectis S.A. will hold its Combined General Meeting of Shareholders on June 28, 2024.
What time will the shareholder meeting begin?
The meeting will begin at 2:30 p.m. Paris time.
Where will the shareholder meeting take place?
The meeting will be held at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.
What is the purpose of this filing?
This filing is a Report of Foreign Private Issuer (Form 6-K) announcing the date, time, and location of the Company's Combined General Meeting of Shareholders.
Is the Notice of Combined General Meeting of Shareholders included with this filing?
Yes, the Notice of Combined General Meeting of Shareholders is attached as an Exhibit (Exhibit Title 99.1) and is incorporated by reference.
Filing Stats: 211 words · 1 min read · ~1 pages · Grade level 9.1 · Accepted 2024-05-24 16:06:01
Filing Documents
- d714335d6k.htm (6-K) — 10KB
- d714335dex991.htm (EX-99.1) — 287KB
- 0001193125-24-147032.txt ( ) — 298KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CELLECTIS S.A. May 24, 2024 By: /s/ André Choulika André Choulika Chief Executive Officer